NATDECITA 50MG

Natdecita 50mg injection contains decitabine as its active ingredient. This antineoplastic medication falls under the category of DNA methylation inhibitors. It is utilized in the treatment of myelodysplastic syndrome, which refers to a collection of disorders where the bone marrow generates misshapen blood cells that fail to produce a sufficient number of healthy blood cells. Additionally, it is employed in treating acute myeloid leukemia (AML), a specific type of cancer. The drug functions by inhibiting the growth of cancer cells.

You should not receive this injection if you have an allergy to Natdecita 50mg injection or any of its components. Notify your doctor if you have an infection, low blood cell count, liver disease, kidney issues, or heart problems. This medication is not advised for individuals under 18 years of age. It may lead to a serious immune response known as differentiation syndrome. If you experience sudden breathing difficulties, cough, fever, or swelling, contact your physician immediately.

Natdecita 50mg injection is contraindicated for use in pregnant or breastfeeding women. Make sure to inform your doctor if you are pregnant or nursing. It is essential to use effective contraception during treatment to prevent pregnancy. Common side effects include reduced counts of white blood cells, red blood cells, and platelets, as well as elevated body temperature.